In the neuroblastoma cell line, the E2F-targeted portions of cancer pathways, thermogenesis, mTOR signaling, insulin signaling, and circadian entrainment were all inhibited (Fig. 5B), as one would expect based on the previous research on E2F1. Here, E2F1 is linked to neuroblastoma.